View the PowerPoint with the presenter here: http://www.redchip.com/events/12/apri... Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and services some of the most prestigious medical institutions in the world. The Company’s tests target cancers that are difficult to diagnose and predict treatment outcomes. Its state-of-the-art reference lab is focused entirely on maintaining clinical excellence and is both CLIA certified and CAP accredited and has licensure from several states including New York State. CGIX has established strong research collaborations and agreements with major cancer centers such as Mayo Clinic, Memorial Sloan-Kettering, The Cleveland Clinic and the National Cancer Institute. The Company has also established a high-profile clinical trial partnership with Gilead Sciences through its SelectOne program. Visit www.redchip.com for more information.
Cancer Genetics Q&A Session at RedChip's April 2017 Conference - YouTube |
| 1 Likes | 1 Dislikes |
| 343 views views | followers |
| Education | Upload TimePublished on 2 May 2017 |
Không có nhận xét nào:
Đăng nhận xét